HAE · Haemonetics Corp · Share Buybacks
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
| Program Announced | Authorized | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| — | $500,000,000 | $425,000,000 | 2025-09-27 | — | 8-K , filed 2025-11-06 |
Cash spent on buybacks by quarter
Cash deployed each quarter, with the average price paid where the company reported it. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2026-03-28 | $175,000,000 | 10-K, filed 2026-05-20 |
| 2025-03-29 | $225,000,000 | 10-K, filed 2026-05-20 |
| 2024-03-30 | $0 | 10-K, filed 2026-05-20 |
| 2023-04-01 | $75,000,000 | 10-K, filed 2025-05-21 |
| 2022-04-02 | $0 | 10-K, filed 2024-05-20 |
| 2021-04-03 | $0 | 10-K, filed 2023-05-22 |
| 2020-03-28 | $175,000,000 | 10-K, filed 2022-05-25 |
| 2019-03-30 | $160,000,000 | 10-K, filed 2021-05-26 |
| 2018-03-31 | $100,000,000 | 10-K, filed 2020-05-20 |
| 2017-04-01 | $0 | 10-K, filed 2019-05-22 |
| 2016-04-02 | $60,984,000 | 10-K, filed 2018-05-23 |
| 2015-03-28 | $39,033,000 | 10-K, filed 2017-05-24 |
| 2014-03-29 | $0 | 10-K, filed 2016-06-01 |
| 2013-03-30 | $50,000,000 | 10-K, filed 2015-05-22 |
| 2012-03-31 | $49,998,000 | 10-K, filed 2014-05-22 |
| 2011-04-02 | $50,000,000 | 10-K, filed 2013-05-20 |
| 2010-04-03 | $40,000,000 | 10-K, filed 2012-05-22 |
| 2009-03-28 | $59,998,000 | 10-K, filed 2011-05-26 |